Transperineal Ultrasound for the Female Pelvic Floor in Women With Multiple Gestation
NCT ID: NCT00790504
Last Updated: 2017-05-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2008-11-30
2012-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The 3-Dimensional Ultrasound for Fetal Anomaly Scan
NCT00966537
Tridimensional Pelvic Floor Ultrasound and Quality of Life Scores Questionnaires in Nulliparous or Parous Women
NCT03656601
Sonopartogram. The Next Step in the Delivery Room
NCT02326077
Is Early Second Trimester Vaginal Ultrasound Scan Associated With Adverse Perinatal Outcomes?
NCT00909376
The Accuracy of Ultrasound in the Detection of Placenta Site in the First Trimester.
NCT04579796
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1 study group
Women with multiple gestations recruited from the prenatal care or high risk pregnancy units
No interventions assigned to this group
2 control group
Women with singleton gestation recruited from the prenatal care or high risk pregnancy units
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Women with singleton gestation
* Able to understand the consent form
Exclusion Criteria
17 Years
60 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sheba Medical Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Vered Eisenberg
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Vered H Eisenberg, MD MHA
Role: PRINCIPAL_INVESTIGATOR
Sheba Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sheba Medical Center
Ramat Gan, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SHEBA-08-5470-VE-CTIL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.